BIOMAT Database Logo BIOMAT Database Logo

Effect of fluorine substitution on the adrenergic properties of 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol. 1991

A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
Laboratory of Bioorganic Chemistry, National Institute of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

The 2- and 6-fluoro derivatives of the potent beta-adrenergic agonist 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol were prepared and their adrenergic properties examined. The order of potency was as follows: beta-adrenergic activity (simulation of cyclic AMP formation in C6 glioma cells), 2-F = parent much greater than 6-F; beta 1-activity (rate of contraction, guinea pig atria), parent greater than 2-F much greater than 6-F; beta 2-activity (relaxation of guinea pig tracheal strip), 2-F greater than parent much greater than 6-F. The affinity of the 2-fluoro analogue for beta 1-adrenergic receptors (inhibition of the specific binding of [3H]dihydroalprenolol, rat cerebral cortical membranes) was 2 times greater, while the 6-fluoro analogue was 1450 times less than the parent. These results suggest that the aromatic rings of phenoxypropanolamine adrenergic agonists and phenylethanolamine adrenergic agonists bind in similar fashion to the adrenergic receptor, and that if interactions between fluorine and the side-chain hydroxyl group are critical in defining beta-adrenergic selectivity, the interactions are similar in both phenoxypropanolamines and phenylethanolamines.

UI MeSH Term Description Entries
D008297 Male Males
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004082 Dihydroalprenolol Hydrogenated alprenolol derivative where the extra hydrogens are often tritiated. This radiolabeled form of ALPRENOLOL, a beta-adrenergic blocker, is used to label the beta-adrenergic receptor for isolation and study. 1-((Methylethyl)amino)-3-(2-propylphenoxy)-2-propanol
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19

Related Publications

A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
August 1972, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
April 1972, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Studies on cardiovascular drugs. 8. Metabolism of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
March 1972, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.
February 1985, Chemical & pharmaceutical bulletin,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
May 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
Adrenergic agents. 8.1 Synthesis and beta-adrenergic agonist activity of some 3-tert-butylamino-2-(substituted phenyl)-1-propanols.
October 1977, Journal of medicinal chemistry,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
March 1972, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
May 1983, Journal of medicinal chemistry,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
[Synthesis of optically active 5- (3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride and their beta-adrenergic blocking activities (author's transl)].
March 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Adejare, and J Y Nie, and D Hebel, and L E Brackett, and O Choi, and F Gusovsky, and W L Padgett, and J W Daly, and C R Creveling, and K L Kirk
Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
February 1972, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!